From January 1, 2022 to March 13, 2022, the company has repurchased 860,800 shares, representing 0.14% for CNY 9.03 million. With this, the company has completed the repurchase of 5,000,000 shares, representing 0.81% for CNY 59.98 million under the buyback announced on March 15, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 CNY | -1.54% | -0.78% | -20.31% |
1st Jan change | Capi. | |
---|---|---|
-20.31% | 431M | |
+21.62% | 43.81B | |
+25.56% | 23.01B | |
+18.81% | 15.27B | |
+10.23% | 13.68B | |
+43.64% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.